Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Astracytron Forte
- Development stage
- Unknown
- Lead developer
- Astrapharm
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Astracytron Forte is an over-the-counter (OTC) small-molecule combination drug developed and manufactured by the Ukrainian pharmaceutical company Astrapharm. Formulated as a powder for oral solution in sachets, it contains a combination of paracetamol (acetaminophen), phenylephrine hydrochloride, pheniramine maleate, and ascorbic acid (vitamin C). The product is indicated for the symptomatic relief of acute respiratory infections (colds) and influenza in adults and children over 14 years of age. Its active components provide combined antipyretic, analgesic, anti-inflammatory, and vasoconstrictor effects, helping to alleviate symptoms such as fever, headache, runny nose, sneezing, lacrimation, and nasal congestion.
- Brand names
- Astracitron ForteAstracytron Forte
- Other names
- ascorbic acid + paracetamol + pheniramine + phenylephrine
02
Targets
ADRA1A (α1A)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on Astracytron Forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Astracytron Forte.